buttonA A A

Healthcare Professionals

SLO-NIACIN® is clinically proven to support heart health in the SLIM study and HATS trial

SLO-NIACIN® (polygel® controlled-release niacin) is the #1 preferred niacin supplement with nicotinic acid.1

  • Niacin is clinically proven to support heart health
    • Shown to be beneficial in the Coronary Drug Project2
    • Improved HDL and blood lipid levels alone or with a statin3-5
    • Reduced risk of cardiovascular events* when combined with a statin5
    • Halted stenosis progression when combined with a statin5
  • 3 dosage strengths of SLO-NIACIN® Tablets are available to help meet individual goals6
  • Unique, patented polygel® system delivers controlled-release niacin (nicotinic acid)6
  • An economical choice for today’s patients, SLO-NIACIN® Tablets are available at pharmacies and other retailers nationwide7
  • Request samples of SLO-NIACIN® Tablets today
  • Used for more than 20 years and manufactured by Upsher-Smith Laboratories, Inc., a trusted manufacturer of high-quality prescription and dietary supplement products

Next: Clinically Proven


*Composite of death from cardiovascular causes, nonfatal infarction, or revascularization procedures.


SLO-NIACIN® Tablets are a niacin dietary supplement shown in clinical studies to raise good cholesterol. With controlled-release niacin, SLO-NIACIN® Tablets gradually release nicotinic acid and are designed to reduce the incidence of flushing and itching commonly associated with niacin use.

These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.

Read the information leaflet provided with each bottle of SLO-NIACIN® Tablets.

Patients taking more than 500 mg of niacin daily should only do so under the care and monitoring of a physician. Niacin may cause temporary flushing, particularly when beginning, increasing dosage, or changing brands. Case reports of myopathy have been documented with the use of HMG-CoA Reductase Inhibitors in combination with lipid-altering doses of niacin therapy (≥1 gram of niacin per day). Although rare, abnormal liver function tests have been reported in persons taking daily doses of 500 mg or more of niacin.

This safety information is not all-inclusive. For more information, call 1-800-654-2299.